Ropinirole Hydrochloride Patent Expiration

Ropinirole Hydrochloride is used for treating Parkinson's syndrome. It was first introduced by Glaxosmithkline Llc in its drug Requip on Sep 19, 1997. Another drug containing Ropinirole Hydrochloride is Requip Xl. 19 different companies have introduced drugs containing Ropinirole Hydrochloride.

Ropinirole Hydrochloride Patents

Given below is the list of patents protecting Ropinirole Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Requip Xl	US7927624	Hydrophilic/lipophilic polymeric matrix dosage formulation	Dec 02, 2021 (Expired)	Glaxosmithkline Llc
Requip Xl	US8303986	Hydrophilic/lipophilic polymeric matrix dosage formulation	Apr 12, 2021 (Expired)	Glaxosmithkline Llc

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ropinirole Hydrochloride's patents.

Latest Legal Activities on Ropinirole Hydrochloride's Patents

Given below is the list recent legal activities going on the following patents of Ropinirole Hydrochloride.

Activity	Date	Patent Number

Maintenance Fee Reminder Mailed Critical	24 Jun, 2024	US8303986
Expire Patent Critical	22 May, 2023	US7927624
Maintenance Fee Reminder Mailed Critical	05 Dec, 2022	US7927624
Payment of Maintenance Fee, 8th Year, Large Entity	21 Apr, 2020	US8303986
Payment of Maintenance Fee, 8th Year, Large Entity	09 Oct, 2018	US7927624
Recordation of Patent Grant Mailed Critical	06 Nov, 2012	US8303986
Patent Issue Date Used in PTA Calculation Critical	06 Nov, 2012	US8303986
Email Notification Critical	18 Oct, 2012	US8303986
Issue Notification Mailed Critical	17 Oct, 2012	US8303986
Dispatch to FDC	02 Oct, 2012	US8303986

Ropinirole Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Ropinirole Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Ropinirole Hydrochloride. The first generic version for Ropinirole Hydrochloride was by Cosette Pharmaceuticals Inc and was approved on May 5, 2008. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on May 11, 2022.

Given below is the list of companies who have filed for Ropinirole Hydrochloride generic, along with the locations of their manufacturing plants worldwide.

1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Feb 28, 2017

2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	May 17, 2012
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	May 17, 2012
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	May 17, 2012
EQ 2MG BASE	tablet, extended release	Prescription	ORAL	AB	May 17, 2012
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	May 17, 2012

Manufacturing Plant Locations
^New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country

City

Firm Name

United States

Elizabeth

Actavis Elizabeth LLC, A Company of Teva

3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 2MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 22, 2013
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 22, 2013
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 22, 2013
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 22, 2013
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 22, 2013

Manufacturing Plant Locations
^New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country

City

Firm Name

India

Panelav	Alembic Pharmaceuticals Limited
Panchmahal	Alembic Pharmaceuticals Limited (Units I and II)
Vadodara	Alembic Pharmaceuticals Limited
Vadodara	Alembic Pharmaceuticals Ltd
Vadodara	Alembic Pharmaceuticals, Ltd
Vadodara	Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panchmahal	Alembic Pharmaceuticals Limited

4. ALEMBIC LTD

Alembic Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Mar 24, 2010

5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2012
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	May 29, 2008
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	May 29, 2008
EQ 1MG BASE	tablet	Prescription	ORAL	AB	May 29, 2008
EQ 2MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2012
EQ 3MG BASE	tablet	Prescription	ORAL	AB	May 29, 2008
EQ 5MG BASE	tablet	Prescription	ORAL	AB	May 29, 2008
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2012
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2012
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2012

6. COSETTE

Cosette Pharmaceuticals Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Cosette.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.5MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 0.25MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 1MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 2MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 3MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 4MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 5MG BASE	tablet	Discontinued	ORAL	N/A	May 19, 2008

Manufacturing Plant Locations
^New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country

City

Firm Name

United States

South Plainfield	Cosette Pharmaceuticals, Inc.
Lincolnton	Cosette Pharmaceuticals NC Laboratories, LLC

7. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 2MG BASE (reference standard)	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012

8. EPIC PHARMA LLC

Epic Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 1MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 2MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 3MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 4MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 5MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 0.25MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008
EQ 0.5MG BASE	tablet	Discontinued	ORAL	N/A	May 20, 2008

9. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Feb 25, 2010

10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 0.5MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 1MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 2MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 3MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 4MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 5MG BASE	tablet	Discontinued	ORAL	N/A	May 19, 2008

Manufacturing Plant Locations
^New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country

City

Firm Name

United States

Eatontown	Hikma Pharmaceuticals USA, Inc.
Cherry Hill	Hikma Pharmaceuticals USA Inc.
Carlsbad	Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton	Hikma Injectables USA Inc

Portugal

Terrugem Snt

Hikma Farmaceutica, (Portugal) S.A.

Jordan

Amman

Hikma Pharmaceuticals LLC

11. MLV

Mlv Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mlv.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Feb 7, 2012

12. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 3MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012
EQ 4MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012
EQ 6MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012
EQ 8MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012
EQ 12MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012
EQ 2MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Oct 15, 2012

13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 0.5MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 1MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 2MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 3MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 4MG BASE	tablet	Discontinued	ORAL	N/A	May 5, 2008
EQ 5MG BASE	tablet	Discontinued	ORAL	N/A	May 19, 2008

14. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Nov 28, 2012

15. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 0.25MG BASE (reference standard)	tablet	Prescription	ORAL	AB	May 5, 2008
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	May 5, 2008
EQ 1MG BASE	tablet	Prescription	ORAL	AB	May 5, 2008
EQ 2MG BASE	tablet, extended release	Prescription	ORAL	AB	May 11, 2022
EQ 3MG BASE	tablet	Prescription	ORAL	AB	May 5, 2008
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	May 11, 2022
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Jul 11, 2008
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	May 11, 2022
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	May 11, 2022
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	May 11, 2022

16. SANDOZ INC

Sandoz Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 2MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 4MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 6MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 8MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012
EQ 12MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 6, 2012

Manufacturing Plant Locations
^New

Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.

Country

City

Firm Name

United States

East Hanover	Sandoz Incorporated
Princeton	Sandoz Inc

17. WATSON LABS INC

Watson Laboratories Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 2MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 6, 2012
EQ 4MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 6, 2012
EQ 6MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 6, 2012
EQ 8MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 6, 2012
EQ 12MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 6, 2012

18. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 4MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 2MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 1MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 0.5MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 0.25MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 5MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009
EQ 3MG BASE	tablet	Prescription	ORAL	AB	Jun 1, 2009

Manufacturing Plant Locations
^New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country

City

Firm Name

India

Ahmedabad	ZYDUS LIFESCIENCES LIMITED
Ankleshwar	Zydus Lifesciences Limited
Ahmedabad	Zydus Lifesciences Limited
Jarod	Zydus Lifesciences Limited
District Solan	Zydus Lifesciences Limited
Thane	Zydus Lifesciences Limited
Matoda	Zydus Lifesciences Limited
Moraiya, Ahmedabad	Zydus Lifesciences Limited
Dabhasa	Zydus Lifesciences Limited

Pharsight

Pharsight

Ropinirole Hydrochloride Patent Expiration

Ropinirole Hydrochloride Patents

Latest Legal Activities on Ropinirole Hydrochloride's Patents

Ropinirole Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Ropinirole Hydrochloride Generic API Manufacturers

1. ACCORD HLTHCARE

2. ACTAVIS ELIZABETH

Manufacturing Plant Locations
^New

3. ALEMBIC

Manufacturing Plant Locations
^New

4. ALEMBIC LTD

5. CHARTWELL RX

6. COSETTE

Manufacturing Plant Locations
^New

7. DR REDDYS LABS LTD

8. EPIC PHARMA LLC

9. GLENMARK PHARMS LTD

10. HIKMA

Manufacturing Plant Locations
^New

11. MLV

12. MYLAN PHARMS INC

13. NORVIUM BIOSCIENCE

14. ORBION PHARMS

15. PRINSTON INC

16. SANDOZ INC

Manufacturing Plant Locations
^New

17. WATSON LABS INC

18. ZYDUS LIFESCIENCES

Manufacturing Plant Locations
^New

Have Questions?

Pharsight

Pharsight

Ropinirole Hydrochloride Patents

Latest Legal Activities on Ropinirole Hydrochloride's Patents

Ropinirole Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Ropinirole Hydrochloride Generic API Manufacturers

1. ACCORD HLTHCARE

2. ACTAVIS ELIZABETH

Manufacturing Plant Locations New

3. ALEMBIC

Manufacturing Plant Locations New

4. ALEMBIC LTD

5. CHARTWELL RX

6. COSETTE

Manufacturing Plant Locations New

7. DR REDDYS LABS LTD

8. EPIC PHARMA LLC

9. GLENMARK PHARMS LTD

10. HIKMA

Manufacturing Plant Locations New

11. MLV

12. MYLAN PHARMS INC

13. NORVIUM BIOSCIENCE

14. ORBION PHARMS

15. PRINSTON INC

16. SANDOZ INC

Manufacturing Plant Locations New

17. WATSON LABS INC

18. ZYDUS LIFESCIENCES

Manufacturing Plant Locations New

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New